• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌相关基因中突变等位基因的偏性表达。

Biased expression of mutant alleles in cancer-related genes in esophageal squamous cell carcinoma.

机构信息

Department of Frontier Surgery, Graduated School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba City, Chiba, Japan.

Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.

出版信息

Esophagus. 2022 Apr;19(2):294-302. doi: 10.1007/s10388-021-00900-7. Epub 2022 Jan 11.

DOI:10.1007/s10388-021-00900-7
PMID:35013873
Abstract

BACKGROUND

Recent progress of large-scale international studies has provided comprehensive catalogs of somatic mutations in cancers. Additionally, it has become evident that allelic imbalance in the abundance of somatic mutations between DNA and RNA were pervasive in various types of cancer. However, the allelic imbalance of the abundance of somatic mutations in esophageal squamous cell carcinoma (ESCC) has not been fully analyzed.

METHODS

We performed exome sequencing for 25 Japanese patients with ESCC to detect a comprehensive catalog of somatic mutations in ESCC. Additionally, we performed mRNA sequencing to evaluate the allelic imbalance of the identified somatic mutations at the transcriptional level by comparing the mutant allele frequencies between RNA and DNA.

RESULTS

The exome sequencing showed that TP53 and ZNF750 were significantly mutated genes. The expression levels of TP53 and ZNF750 were different depending on the mutation status. In almost all the tumors with missense mutations in TP53 and ZNF750, the mutant allele frequencies were higher in the RNA sequencing than those in the exome sequencing, indicating that the mutant alleles were preferentially expressed. By examining the allelic imbalances for all the identified missense mutations, we demonstrated that genes showing preferential expressions of the mutant alleles were involved in the pathways including cell cycle, cell death, and chromatin modification.

CONCLUSIONS

The results of this study suggest that the allelic imbalance of the abundance of somatic mutations plays important roles in the initiation and progression of ESCC by modulating cancer-related biological pathways.

摘要

背景

最近大规模国际研究的进展提供了癌症中体细胞突变的综合目录。此外,显然在各种类型的癌症中,DNA 和 RNA 之间体细胞突变丰度的等位基因不平衡是普遍存在的。然而,食管鳞状细胞癌(ESCC)中体细胞突变丰度的等位基因不平衡尚未得到充分分析。

方法

我们对 25 名日本 ESCC 患者进行了外显子组测序,以检测 ESCC 中体细胞突变的综合目录。此外,我们进行了 mRNA 测序,通过比较 RNA 和 DNA 之间的突变等位基因频率,评估鉴定出的体细胞突变在转录水平上的等位基因不平衡。

结果

外显子组测序显示 TP53 和 ZNF750 是显著突变的基因。TP53 和 ZNF750 的表达水平因突变状态而异。在 TP53 和 ZNF750 错义突变的几乎所有肿瘤中,RNA 测序中的突变等位基因频率均高于外显子组测序中的突变等位基因频率,表明突变等位基因优先表达。通过检查所有鉴定出的错义突变的等位基因不平衡,我们证明了优先表达突变等位基因的基因参与了包括细胞周期、细胞死亡和染色质修饰在内的途径。

结论

这项研究的结果表明,通过调节与癌症相关的生物学途径,体细胞突变丰度的等位基因不平衡在 ESCC 的发生和发展中起着重要作用。

相似文献

1
Biased expression of mutant alleles in cancer-related genes in esophageal squamous cell carcinoma.食管癌相关基因中突变等位基因的偏性表达。
Esophagus. 2022 Apr;19(2):294-302. doi: 10.1007/s10388-021-00900-7. Epub 2022 Jan 11.
2
Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.全外显子组测序揭示食管鳞癌转移的关键基因。
J Pathol. 2017 Aug;242(4):500-510. doi: 10.1002/path.4925. Epub 2017 Jul 12.
3
An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.一则重述的旧故事:G1 调控缺失定义了食管鳞状细胞癌的一种独特基因组亚型。
Genomics Proteomics Bioinformatics. 2015 Aug;13(4):258-70. doi: 10.1016/j.gpb.2015.06.003. Epub 2015 Sep 16.
4
PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.PRIMA-1通过上调Noxa在具有TP53错义突变的食管鳞状细胞癌中诱导p53介导的细胞凋亡。
Cancer Sci. 2018 Feb;109(2):412-421. doi: 10.1111/cas.13454. Epub 2017 Dec 28.
5
Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma.基因组分析揭示了食管鳞状细胞癌中的突变特征和频繁改变的基因。
Am J Hum Genet. 2015 Apr 2;96(4):597-611. doi: 10.1016/j.ajhg.2015.02.017.
6
Novel oncogenic transcriptional targets of mutant p53 in esophageal squamous cell carcinoma.食管癌中突变型 p53 的新型致癌转录靶标。
J Cell Biochem. 2024 Apr;125(4):e30534. doi: 10.1002/jcb.30534. Epub 2024 Feb 15.
7
Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma.突变型TP53 G245C和R273H促进食管鳞状细胞癌的细胞恶性增殖。
BMC Cell Biol. 2018 Aug 20;19(1):16. doi: 10.1186/s12860-018-0167-y.
8
Integrative genome-wide analyses reveal the transcriptional aberrations in Japanese esophageal squamous cell carcinoma.综合全基因组分析揭示了日本食管鳞状细胞癌中的转录异常。
Cancer Sci. 2021 Oct;112(10):4377-4392. doi: 10.1111/cas.15063. Epub 2021 Aug 12.
9
Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation.使用低质量血清对食管鳞状细胞癌游离DNA进行靶向深度测序:与肿瘤突变的一致性
Int J Mol Sci. 2021 May 26;22(11):5627. doi: 10.3390/ijms22115627.
10
Allelic loss on chromosome 13q14 and mutation in deleted in cancer 1 gene in esophageal squamous cell carcinoma.
Oncogene. 2003 Jan 16;22(2):314-8. doi: 10.1038/sj.onc.1206098.

引用本文的文献

1
Identification and analysis of oncogenic non-synonymous single nucleotide polymorphisms in the human NRAS gene: An exclusive in silico study.人类NRAS基因致癌性非同义单核苷酸多态性的鉴定与分析:一项独家的计算机模拟研究。
J Genet Eng Biotechnol. 2024 Jun;22(2):100378. doi: 10.1016/j.jgeb.2024.100378. Epub 2024 May 3.
2
NMR structure verifies the eponymous zinc finger domain of transcription factor ZNF750.核磁共振结构验证了转录因子ZNF750的同名锌指结构域。
J Struct Biol X. 2023 Aug 12;8:100093. doi: 10.1016/j.yjsbx.2023.100093. eCollection 2023 Dec.
3
Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making.

本文引用的文献

1
Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial.纳武利尤单抗对比化疗用于既往化疗后进展或不耐受的晚期食管鳞癌患者(ATTRACTION-3):一项多中心、随机、开放标签、III 期临床研究。
Lancet Oncol. 2019 Nov;20(11):1506-1517. doi: 10.1016/S1470-2045(19)30626-6. Epub 2019 Sep 30.
2
Identification of genomic alterations in oesophageal squamous cell cancer.食管鳞状细胞癌的基因组改变鉴定。
Nature. 2014 May 1;509(7498):91-5. doi: 10.1038/nature13176. Epub 2014 Mar 16.
3
利用食管癌的分子基础进行靶向治疗及药物反应生物标志物研究:指导临床决策
Biomedicines. 2022 Sep 22;10(10):2359. doi: 10.3390/biomedicines10102359.
The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer.
17号染色体短臂上等位基因失衡、p53突变与头颈部癌中p53过表达之间的关系。
Int J Oncol. 2001 Aug;19(2):331-6.